Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BN✓SelectedUSD · BNGSK vs BN performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs BN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
BN return
+78.7%
Excess return
-23.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioBNExcessAlpha
1D-1.3%-0.5%-0.8%-1.3%
7D-3.1%-6.3%+3.2%-2.3%
30D-0.9%+8.0%-8.9%-1.7%
3M-4.2%-6.3%+2.2%-3.4%
6M-1.6%-12.3%+10.7%-0.2%
YTD+2.6%-13.7%+16.3%+3.8%
1Y+6.2%-8.7%+14.9%+7.0%
All+55.4%+78.7%-23.3%+42.6%

Cumulative growth

Daily Returns

Daily percentage return beside BN.

Daily Out/Under-Performance

Portfolio return minus BN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded BN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling